Head‐to‐head comparison of GA‐68 PSMA PET/CT and multiparametric MRI findings with postoperative results in preoperative locoregional staging and localization of prostate cancer

Documenti analoghi

• Impact of definitive radiotherapy on metabolic response measured with 68Ga‐PSMA‐PET/CT in patients with intermediate‐risk prostate cancer
  di: Cem Onal, et al.
  Pubblicazione: (2024)
• Role of Volumetric Parameters Derived From Ga‐68 PSMA PET‐CT in Predicting Treatment Response
  di: Ali Uyar, et al.
  Pubblicazione: (2025)
• The predictive impact of hematological inflammatory markers in detecting prostate cancer in patients with PI‐RADS 3 lesions on multiparametric magnetic resonance imaging
  di: Ridvan Kayar, et al.
  Pubblicazione: (2024)
• The Clinical Significance of Gallium‐68 PSMA‐11 PET‐Derived SUVmax in the Management of Metastatic Hormone‐Sensitive Prostate Cancer
  di: Cevat İlteriş Kıkılı, et al.
  Pubblicazione: (2026)
• Incidental Brain Metastases From Prostate Cancer Diagnosed With PSMA PET/CT and MRI: A Case Series and Literature Review
  di: Mark Willy L. Mondia, et al.
  Pubblicazione: (2025)